Advertorial

Dear [Full Name]

This is a reminder that you have registered to view a Live Broadcast on a new treatment option for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.

Thank you for your participation!

  • Date: [Placeholder]

  • Time: [Placeholder]

  • To view the broadcast, please click here.

VIEW LIVE BROADCAST

 

For full Prescribing Information, Click Here

Faculty information

Pharmaceutical Technology Pii

[Speaker 1 - Full Name, Credentials]

[Affiliation name]
[City, State /Country]

Pharmaceutical Technology Pii

[Speaker 2 - Full Name, Credentials]

[Affiliation name]
[City, State /Country]

 
VIEW LIVE BROADCAST
Pharmaceutical Technology Pii

 

This Live Broadcast is sponsored by Karyopharm Therapeutics Inc.
© 2020 Karyopharm Therapeutics Inc. All rights reserved.
US-XPOV-05/20-00030

 

Onclive – an MJH Life Sciences brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Drive, Suite 100
Cranbury, NJ 08512

Preferences  |  Unsubscribe